Lexaria Bioscience (LEXX) Non Operating Investment Income (2018 - 2025)
Lexaria Bioscience (LEXX) recorded Non Operating Investment Income of -$22,093 in fiscal Q1 2026 (quarter ended Nov 30, 2025), compared with -$15,932 a year earlier.
Lexaria Bioscience (LEXX) Non Operating Investment Income (2018 - 2025) Analysis & Trends
For FY2025 (ended Aug 31, 2025), Lexaria Bioscience reported Non Operating Investment Income of -$33,714.
- Across earlier fiscal years, Non Operating Investment Income came in at -$69,835 in FY2024, -$221,693 in FY2023, -$764,614 in FY2022 and $1.52 million in FY2021.
- Quarterly Non Operating Investment Income has ranged from -$2.29 million in fiscal Q4 2022 to $1.52 million in fiscal Q2 2021 over the past five years.
- Per Business Quant, the preceding three fiscal quarters came in at -$11,447 (Q4 2025), -$40,375 (Q3 2025) and $34,040 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Op. Investment Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Lexaria Bioscience | 3.04 Mn | -12.61 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Nov 30, 2025 | -22,093.00 |
| Aug 31, 2025 | -11,447.00 |
| May 31, 2025 | -40,375.00 |
| Feb 28, 2025 | 34,040.00 |
| Nov 30, 2024 | -15,932.00 |
| Aug 31, 2024 | 9,500.00 |
| May 31, 2024 | -41,393.00 |
| Feb 29, 2024 | 15,273.00 |
| Nov 30, 2023 | -53,215.00 |
| Aug 31, 2023 | -143,918.00 |
| May 31, 2023 | 1,856.00 |
| Feb 28, 2023 | -2,003.00 |
| Nov 30, 2022 | -77,628.00 |
| Aug 31, 2022 | -2.29 Mn |
| Feb 28, 2021 | 1.52 Mn |
| Nov 30, 2020 | 24,410.00 |
| Aug 31, 2020 | 18,198.00 |
| May 31, 2020 | -18,198.00 |
| Feb 29, 2020 | 983.00 |
| Nov 30, 2019 | -41,574.00 |
Lexaria Bioscience Non Operating Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LEXX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "LEXX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=LEXX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();